Forte Biosciences, Inc.FBRXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+363.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+363.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
99.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.70M+50.8%
2024$1.12M+11.3%
2023$1.01M+5841.2%
2022$17000.00+107.7%
2021$-222000.00+99.3%
2020$-32.26M-645140.0%
2019$-5000.00+99.6%
2018$-1.40M-7.9%
2017$-1.30M+27.3%
2016$-1.79M-